Glycobreez-F HPMC Capsule belongs to the group of medicines called bronchodilators indicated for long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining). In COPD, the muscles around the airways tighten, making it difficult to breathe.
 
Glycobreez-F HPMC Capsule is a combination of two medicines, namely: Formoterol fumarate (long-acting beta2-adrenergic agonist) and Glycopyrronium (anti-cholinergic). Formoterol fumarate prevents tightening of the muscles in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium decreases the secretions in the airways. Together, Glycobreez-F HPMC Capsule provides relief from COPD.
 
You are advised to use Glycobreez-F HPMC Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience common side-effects such as headache, nausea, dry mouth, chest pain, muscle cramps, dizziness, painful and frequent urination. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
 
Do not stop taking Glycobreez-F HPMC Capsule on your own as it might cause worsening of symptoms. Consult your doctor if you are pregnant or breastfeeding. Glycobreez-F HPMC Capsule may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Glycobreez-F HPMC Capsule is not recommended for children below 18 years as safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid unpleasant side effects.

Glycobreez-F HPMC Capsule is a combination of two medicines, namely: Formoterol fumarate and Glycopyrronium. Glycobreez-F HPMC Capsule belongs to the group of medicines called bronchodilators used to treat Chronic Obstructive Pulmonary Disease (COPD). Formoterol fumarate is a long-acting beta-agonist that prevents the tightening of the muscles in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium is an anti-cholinergic that decreases the secretions in the airways. Together, Glycobreez-F HPMC Capsule provides relief from COPD.

Do not use Glycobreez-F HPMC Capsule if you are allergic to any of its contents. Inform your doctor if you have asthma, heart problems, seizures/epilepsy, thyroid gland problems, diabetes, narrow-angle glaucoma, kidney problems, severe liver problems, if you have any difficulty in passing urine or if you are taking any medicines for lung diseases. Consult your doctor if you are pregnant or breastfeeding. Glycobreez-F HPMC Capsule may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Glycobreez-F HPMC Capsule is not recommended for children below 18 years as safety and effectiveness have not been established.